Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Rhea-AI Summary
Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology biopharmaceutical company, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City. The company's presentation is scheduled for Wednesday, December 4, 2024, from 9:50-10:10 AM EST. A webcast of the presentation will be available and archived for 90 days on Compass' Events page.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, CMPX gained 1.84%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Piper Sandler 36th Annual Healthcare Conference taking place in New York City, NY December 3-5, 2024.
Presentation details
Date: Wednesday, December 4, 2024
Time: 9:50-10:10 AM EST
Webcast Link: https://event.webcasts.com/
Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.
Investor Contact
ir@compasstherapeutics.com
Media Contact
Anna Gifford, Senior Manager of Communications
media@compasstherapeutics.com
617-500-8099
FAQ
When is Compass Therapeutics (CMPX) presenting at the Piper Sandler Healthcare Conference 2024?
How long will the Compass Therapeutics (CMPX) Piper Sandler conference presentation be available for replay?
Where is the 2024 Piper Sandler Healthcare Conference with Compass Therapeutics (CMPX) being held?
